African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2288

Full Length Research Paper

Effect of ulinastatin preconditioning on the expression of hemeoxygenase-1 in limb ischemia reperfusion lung injury in rats

Fan Li-hua1, Lu Xiang-hong1, Li Jun2*, Zhou wei2 and Lian Qing-Quan2
1Department of Anesthesiology, Wenzhou Medical College, the sixth Affiliated Hospital, Zhejiang Lishui 323000, China. 2Department of Anesthesiology, Wenzhou Medical College, the second Affiliated Hospital, Zhejiang Wenzhou 325027, China.
Email: [email protected]

  •  Accepted: 12 May 2011
  •  Published: 30 June 2011

Abstract

To investigate the role of HO-1 in ischemic preconditioning and pharmacological preconditioning by ulinastatin in attenuating remote lung injury in rat model of lower limb ischemia reperfusion. Sixty four male SD rats were randomly divided into four groups: Sham operation group, ischemia and reperfusion group, ischemia preconditioning group (IPR), ulinastatin preconditioning group (UTI). The animals were deeply anesthetized and the lung tissue was removed at the end of the experiment. Lung W/D ratio were measured and the expression of HO-1 was determined by Immunohistochemical staining and western blotting. HO-1 was induced and expressed persistently in 2 and 4 h after ischemic preconditioning and ulinastatin preconditioning (P<0.01), and the expression in 4 h was higher than 2 h in preconditioning groups (P<0.05). The preconditioning also led to diminished lung edema (W/D ratio) (P<0.05 vs I/R), with no differences when compared to the sham group. The induction of HO-1 by ischemic preconditioning and ulinastatin preconditioning played a protective role against remote lung injury in the model of limb injury/reperfusion.

 

Key words: Heme oxygenase-1, preconditioning, ulinastatin, ischemia/reperfusion.